Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

NCT00281983

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada
  • Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
  • Universitaetsklinikum Essen Essen, Germany
  • Universitaetsklinikum Goettingen Göttingen, Germany
View all 13 locations
View Trial Details
Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
View Trial Details
Completed

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

NCT00801281

Conditions
Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
Locations
  • Podkarpacki Oncology Centre Brzozów, Poland
  • Voivodeship Hospital, Oncology Ward Elblag, Poland
  • Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology Gdansk, Poland
  • Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation Katowice, Poland
View Trial Details
Completed

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

NCT01317901

Conditions
B-cell Small Lymphocytic Lymphoma Recurrent, Chronic Disease, Disease Attributes, +19 more
Locations
  • Site Reference ID/Investigator# 61543 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 61542 Augusta, Georgia, United States
  • Site Reference ID/Investigator# 61523 Omaha, Nebraska, United States
  • Site Reference ID/Investigator# 61522 Hackensack, New Jersey, United States
View Trial Details
Completed

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

NCT00614042

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations
  • For additional information regarding sites for this trial call 919-319-9374 Birmingham, Alabama, United States
  • For additional information regarding sites for this trial call 919-319-9374 Augusta, Georgia, United States
  • For additional information regarding sites for this trial call 919-319-9374 Boston, Massachusetts, United States
  • For additional information regarding sites for this trial call 919-319-9374 Las Vegas, Nevada, United States
View Trial Details

Related conditions